Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. - Wikidata - awgldk - TriplyDB

Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.

Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.

http://www.wikidata.org/entity/Q34533542

about

The role of microRNAs in bladder cancer Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis Novel non invasive diagnostic strategies in bladder cancer HypoxamiRs and cancer: from biology to targeted therapy Clinical and pathological implications of miRNA in bladder cancer The microRNA-183 cluster: the family that plays together stays together miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2.Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure Role of microRNA-130a in the pathogeneses of obstructive sleep apnea hypopnea syndrome-associated pulmonary hypertension by targeting the GAX gene Multiple functions of hypoxia-regulated miR-210 in cancer.MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.Cell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs.Macro and small over micro: macromolecules and small molecules that regulate microRNAs.Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer Nitric oxide enhances keratinocyte cell migration by regulating Rho GTPase via cGMP-PKG signalling miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1 Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.MiRNA inhibition in tissue engineering and regenerative medicine.miR-210: fine-tuning the hypoxic response.PAQR3: a novel tumor suppressor gene.Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637.Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage.Cisplatin and Paclitaxel Alter the Expression Pattern of miR-143/145 and miR-183/96/182 Clusters in T24 Bladder Cancer Cells.Aberrant expression of microRNAs in bladder cancer.Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response.miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.Synthesizing oncogenic signal-processing systems that function as both "signal counters" and "signal blockers" in cancer cells.MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1 Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR.A molecular view of the radioresistance of gliomas.Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma.Hypoxia-Induced MicroRNA-210 Targets Neurodegenerative Pathways.

P2860

Q26744149-C892A202-F924-4BD1-A289-F8DC94F62E8A Q26747871-075EF571-6414-4AEE-A7AC-01A8F465AD76 Q26752188-8BA03ED8-3A75-46EB-B8C8-B520A329F23E Q26863298-3E1806F7-543A-4A45-997D-8ECF5DAA7D40 Q27004262-A832B1B0-4EBC-4387-8984-FC87B59D59CD Q28080473-8A48DA4E-4D29-4B8B-BCD0-765611B7161E Q33671054-364B2E1E-5B6A-4147-80B2-EED778C9F87C Q33689126-C501E383-17DC-4E86-BAFD-A45A40166BFE Q33714332-6EB7F408-7547-4790-845E-EA51C5771C02 Q33765128-20523A14-09E7-4F65-A782-7DA399277396 Q34657610-FA59C4E9-2C1B-4087-B02A-9271EDB5AF40 Q34989307-03F6F8F5-DD7D-49EC-87DD-DDBAABC8A0C3 Q35163086-BE339E05-4A5B-41A2-B945-09739939368C Q35201375-A00CFB20-30FE-484D-ABFE-2EF6B308602C Q35209278-4B850390-1C85-4495-9108-E96E6A04960E Q35494926-5EF91659-CBD6-4B51-AB6C-6AFD05DEF25A Q35584609-CB735AA1-F10E-4F6E-B0EA-19AFD84CFA36 Q35740045-8E53B1F2-8C61-47CE-87E1-4D84CFA84262 Q35799937-6172ABD9-2A89-405C-9E08-DED20093B0CE Q35891149-8BC06A81-0BFE-4DAC-84E3-3E73C0AEB6D3 Q36250590-155F956D-5AC3-426C-BFDD-28D0D59A72CA Q36254868-A3BFDE59-5AF9-4D5B-B162-83B96544DE02 Q36292777-BAC0F37A-4ACA-48E3-890F-394510AB6CF4 Q36426830-8C6218DB-CC61-43B7-9173-01DBFAC7D70B Q36992190-A25CBCC7-61B6-4382-B58C-23B7C219081D Q37426879-C7911BEC-B0D8-4947-8E07-5FE1EF2C43D8 Q37700868-C3A1F0E9-FA99-45FB-B8EC-199575676AC5 Q38109811-FD474AF9-EAA1-451D-B716-8B886DAC9269 Q38176255-10C5B79A-DBBC-4F71-BC6F-20E9E3C6CF76 Q38591803-866ADDAA-5202-4D41-A2AB-E87FC3A51AAF Q38760934-FEF072CB-5305-4C83-90FC-DC8D1F862772 Q38899341-217C1DDE-4237-4A89-8669-49A65F1178BA Q39160249-DC4FF9E3-A92B-4F0E-9887-6049013A59ED Q41547637-F87ADD3C-47A8-40A2-B82E-30BA1A8AA2E7 Q42184292-913B9ABB-6AC6-4F7B-8311-FEBF23EB7299 Q42683731-F25A0A1E-D106-4AD1-B853-C5EDF6F0E880 Q47109034-8A97F032-AD51-4A15-9029-2B1E7BF17860 Q50067582-B184EF79-0092-4B37-8A97-9B65B77F9883 Q50129419-77DEF04E-98A3-4C38-BAC6-70FC52F5AD9B Q52320955-722AC835-B175-4B04-9A9D-A43081E59304

P2860

Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.

http://www.wikidata.org/entity/Q34533542

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@ast

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@en

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@nl

type

label

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@ast

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@en

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@nl

prefLabel

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@ast

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@en

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@nl

P1433

Q34533542-A016395E-439A-470F-BA61-714748193E84

P1476

Q34533542-43BD7A2A-7837-4C69-A239-AFD22FFEB08D

P2093

Q34533542-01364D9E-FA45-453F-90DC-4DD0D0E4E598

Q34533542-1C03B796-A36D-4336-B54E-82A0FBCF4951

Q34533542-20F59317-5308-4365-871B-531F2E3BDC7D

Q34533542-3EF45047-8DF8-406C-B3A8-A4A0359F3586

Q34533542-86D554B3-239C-411F-BCE4-F3F94D677ED7

Q34533542-9CA9BAEA-DDF3-449B-BC4B-77914E5B2D96

Q34533542-CE43FF0E-7AE7-4A39-8F37-2A6334E3EF8C

Q34533542-FD75E1D6-F5FC-48F8-B26C-8BE7D5587AF6

P2860

Q34533542-08723752-DF12-46C9-A1D2-90F8781F9B14

Q34533542-0E8EE578-FF7F-4FE4-A335-DDE74C8D6888

Q34533542-1DF1F3A0-E692-471F-8855-09426FEB268F

Q34533542-2E55B227-E150-4D0D-A036-180BC67F7566

Q34533542-2E8FEEDA-B61E-4638-B751-4D3F8A6A649E

Q34533542-300793E6-F5EB-4250-A906-EB96D29DD5C6

Q34533542-3A7FD829-B721-432B-B05A-D7125ACA4CF6

Q34533542-3F8D9010-1F78-44AE-B9AF-3E43100273A6

Q34533542-458F45BD-44BD-4C32-8DD2-A5F8DA93A37F

Q34533542-47553EC0-350F-4F66-9959-683B9114C9EE

P304

Q34533542-142073A6-C484-45AA-A48C-3512D7A25B16

P31

Q34533542-27CE8A94-C898-42B7-A37E-E09C29B3F41A

P356

Q34533542-66279AF8-571A-4223-888C-20D22BB522E0

P407

Q34533542-4DB62876-8F43-4B37-A0CF-4F0F5EBEA7C7

P433

Q34533542-7F3D7506-254D-4443-9653-634631E6613D

P478

Q34533542-A50FC643-9F28-4414-81AC-DE28228805EA

P577

Q34533542-552201E7-FA6B-4C0B-BFF9-8E3D551AACB2

P5875

Q34533542-13866A50-C0A1-4D5E-A9E3-0D14691EF8F1

P698

Q34533542-58DF4CFD-FA45-41C3-8B1A-82229858412F

P932

Q34533542-660D2632-C69D-4681-87BD-8A1A0201A5FA

P356

JOURNAL.PONE.0052280

P1433

P1476

Synthetic miRNA-mowers targeti ...... tosis in bladder cancer cells.

@en

P2093

Hu Zhang

http://www.w3.org/2001/XMLSchema#string

Liping Nie

http://www.w3.org/2001/XMLSchema#string

Pingping Fa

http://www.w3.org/2001/XMLSchema#string

Yaoting Gui

http://www.w3.org/2001/XMLSchema#string

Yonghua Han

http://www.w3.org/2001/XMLSchema#string

Yuchen Liu

http://www.w3.org/2001/XMLSchema#string

Zhimao Jiang

http://www.w3.org/2001/XMLSchema#string

Zhiming Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of differentially expressed microRNAs in human male breast cancer

MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3

Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Argonaute2 is the catalytic engine of mammalian RNAi

microRNA involvement in human cancer

P304

e52280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0052280

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234043804

http://www.w3.org/2001/XMLSchema#string

P698

23284967

http://www.w3.org/2001/XMLSchema#string

P932

3524115

http://www.w3.org/2001/XMLSchema#string